Skip to content

Investigating the effect of ultrasonic hemodynamic monitoring on early detection of changes in hemodynamic and physical indicators of neonates and its stabilization

Investigating the effect of ultrasonic hemodynamic monitoring by nurses on early detection of changes in hemodynamic and physical indicators of neonates and its stabilization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220831055840N1
Enrollment
50
Registered
2023-05-12
Start date
2023-06-05
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Disorders of Neonates.

Interventions

Intervention group: The intervention is performed on neonates aged 24 to 37 weeks. First, their monitoring is done and recorded by the monitoring device of the company Poyandegan Rah Saadat, and then

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 28 Days

Inclusion criteria

Inclusion criteria: 24 to 37 weeks premature neonates Informed and written consent of parents for their neonate's participation in the research

Exclusion criteria

Exclusion criteria: Parents unwillingness to continue participating in the study Morbidity or death of neonates Having emphysema

Design outcomes

Primary

MeasureTime frame
Percentage of neonates with changes in hemodynamic indicators. Timepoint: At the beginning of the study and six weeks after the start of the intervention. Method of measurement: The monitoring device of the company Poindangan Rah Saadat and the ultrasonic monitoring device of cardiac output.;Percentage of neonates with changes in physical indicators. Timepoint: At the beginning of the study and six weeks after the start of the intervention. Method of measurement: Scales of Seka.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahrzad Yaseri

Tehran University of Medical Sciences

shahrzadyaseri@gmail.com+98 21 8843 8521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026